- Poster presentation
- Open Access
T2-STIR CMR imaging can be used to assess myocardium at risk with gadolinium present in an experimental setting
© Nordlund et al; licensee BioMed Central Ltd. 2013
- Published: 30 January 2013
- Cardiovascular Magnetic Resonance
- Infarct Size
- Coronary Occlusion
- Myocardial Perfusion SPECT
- Acute Ischemia
In the situation of an acute coronary occlusion, the myocardium supplied by the affected artery becomes ischemic. This part of the myocardium is at risk of developing infarction unless reperfusion occurs, and is therefore referred to as the myocardium at risk (MaR). Myocardium at risk and infarct size can be used to calculate myocardial salvage when evaluating efficacy of interventional or cardioprotective therapies. Cardiovascular magnetic resonance (CMR) has been shown to enable quantification of MaR using T2-weighted CMR and has been validated for use in patients. There are few studies validating T2-weighted CMR for ex vivo quantification of MaR in experimental studies, especially with presence of a gadolinium-based contrast agent needed for assessment of infarct size. The purpose of this study was to test if the clinically validated T2-weighted short tau inversion recovery (T2-STIR) imaging sequence can be used to assess MaR with gadolinium present in an experimental ex vivo setting.
Acute ischemia was induced in 26 pigs for 40 minutes followed by 4 hours of reperfusion using a closed-chest, catheter-based experimental model. After explantation and preparation of the heart, T2-STIR CMR images were acquired for quantification of MaR. As reference standard for MaR, ex vivo myocardial perfusion SPECT was used. For assessment of infarct size, high resolution T1-weighted CMR images were acquired.
T2-STIR can be used to quantify MaR in an experimental ex-vivo setting with gadolinium present. Furthermore, quantification of the MaR core zone on T2-STIR may enable quantification of infarct size and, consequently, myocardial salvage.
Swedish research council, swedish heart lung foundation, region of skane, medical faculty lund university
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.